respiratory disease
Owlstone Medical Raises $58M in Series D Financing Round
The company said it has a pipeline of research-use-only panels and diagnostic tests that are in development for lung cancer, liver disease, and respiratory disease.
Owlstone Medical Entering Digestive Health Dx Space With Launch of Breath-Based Testing Service
Premium
The company is preparing to provide a clinical testing service that integrates hydrogen and methane biomarkers for digestive health conditions.
DiaSorin to Acquire Luminex for $1.8B
DiaSorin said that the transaction is expected to be immediately accretive to its earnings per share and result in cost synergies of about $55 million within three years.
BioMérieux Nabs CE Mark for RT-PCR SARS-CoV-2, Influenza A/B Assay
The panel simultaneously tests for SARS-CoV-2 and influenza viruses A and B, while a second analysis detects for human respiratory syncytial virus and human metapneumovirus.
Tempus Enters Infectious Disease Market With Large-Scale COVID-19 Testing, Data Initiative
The company recently received FDA Emergency Use Authorization for its SARS-CoV-2 PCR test while its data-driven COVID-19 research initiative is moving along.